Novel peptides and combinations of peptides for use in immunotherapy against lung and other cancers such as NSCLC, SCLC

摘要

The present invention relates to peptides, proteins, nucleic acids and cells for use in immunotherapy methods. In particular, the present invention relates to immunotherapy of cancer. The present invention also relates to tumor associated T cells, either alone or in combination with other tumor associated peptides, which may serve as active pharmaceutical components of the vaccine composition, for example, to promote an antitumor immune response or to promote the cell in vitro to transfer to a patient. It is about an epitope. Peptides bound to molecules of the major histocompatibility complex (MHC) or such peptides may be targets of antibodies, soluble T cell receptors and other binding molecules.